Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Effects of Targeting the Interleukin-1 Receptor in a Murine Model of Sickle Cell Disease

Jessica Venugopal, PhD, Jintao Wang, PhD, Chiao Guo, Daniel Eitzman, MD

Blood (2019) 134 (Supplement_1): 2259.

https://doi.org/10.1182/blood-2019-128980

Published: 2019

Journal Articles

Neurological Adverse Events Following CAR-T Cell Therapy: A Real-World Analysis of Adult Patients Treated with Axicabtagene Ciloleucel or Tisagenlecleucel

Ajeet Gajra, MD FACP, Marjorie E Zettler, PhD MPH, Eli G Phillips Jr., PharmD, JD, Andrew J Klink, PhD MPH, Jonathan K. Kish, PhD MPH, Sonam Mehta, Bruce Feinberg, DO

Blood (2019) 134 (Supplement_1): 1952.

https://doi.org/10.1182/blood-2019-129593

Published: 2019

Journal Articles

The Effect of the Soluble Guanylate Cyclase Stimulator Olinciguat on Renal Function and Biomarkers of Inflammation and Renal Injury in Sickle Cell Mice

Boris Tchernychev, PhD, Raghunath Ramanarasimhaiah, MD, Guang Liu, PhD, Katherine Hall, PhD, Regina Margaret Graul, PhD, Jaime Masferrer, PhD

Blood (2019) 134 (Supplement_1): 3554.

https://doi.org/10.1182/blood-2019-127361

Published: 2019

Journal Articles

Elevated Axicabtagene Ciloleucel (CAR-19) Expansion By Immunophenotyping Is Associated with Toxicity in Diffuse Large B-Cell Lymphoma

Blood (2018) 132 (Supplement 1): 576.

https://doi.org/10.1182/blood-2018-99-113261

Published: 2018

Journal Articles

Targeting Macrophage Activation in Hyperhemolysis Syndrome with Novel Use of Tocilizumab

Lauren E Lee, MD, Bradley W Beeler, MD, Aaron T Henderson, DO, Brendan C Graham, MD, Michael B Osswald, MD, Nay Win, MBBS, FRCP, FRCPath, CTM (Edin), Andrew P Cap, MD PhD

Blood (2018) 132 (Supplement 1): 4933.

https://doi.org/10.1182/blood-2018-99-110529

Published: 2018

Journal Articles

The Clinical-Stage sGC Stimulator IW-1701 Prevents Increase of Plasma Biomarkers of Intravascular Inflammation and Suppresses Leukocyte-Endothelial Interactions in Tnfα-Treated Mice

Boris Tchernychev, Susanne Feil, Peter Germano, William Warren, Elisabeth Lonie, Robert Feil, Todd G Milne, John Hadcock, Yueh-Tyng Chien, Mark G Currie, Regina Margaret Graul

Blood (2017) 130 (Supplement 1): 447.

https://doi.org/10.1182/blood.V130.Suppl_1.447.447

Published: 2017

Journal Articles

Posterior Reversible Encephalopathy Syndrome (PRES) after Infusion of Anti-Bcma CAR T Cells (CART-BCMA) for Multiple Myeloma: Successful Treatment with Cyclophosphamide

Alfred L. Garfall, MD, Eric Lancaster, MD PhD, Edward A Stadtmauer, MD, Simon F. Lacey, PhD, Karen Dengel, BSN, RN, David E Ambrose, BS, Fang Chen, PhD, Minnal Gupta, MSc, Irina Kulikovskaya, PhD, Dan T. Vogl, MD, Gabriela Plesa, PhD, Brendan M Weiss, MD, Regina Ferthio, Celeste Richardson, PhD, Jan Joseph Melenhorst, PhD, Bruce L Levine, PhD, Carl H June, MD, Michael Milone, MD PhD, Adam D. Cohen, MD

Blood (2016) 128 (22): 5702.

https://doi.org/10.1182/blood.V128.22.5702.5702

Published: 2016

Journal Articles

Translation from SCD Mouse to Man: Chronic Administration of Tucaresol Reduces RBC Sickling and Improves Hematological Parameters, but Does Not Impact Inflammatory Markers in SCD Model Mice

Kelly Marie Knee, Reema Jasuja, Amey Barakat, John J. Kelly, Joseph C. Nneji, Pratap Singh, Jay M. Janz

Blood (2016) 128 (22): 3644.

https://doi.org/10.1182/blood.V128.22.3644.3644

Published: 2016

Journal Articles

E-Selectin Antagonist GMI-1271 Shows a Favorable Safety, PK and Bleeding Profile in Phase I Studies of Healthy Volunteers

Dana E. Angelini, MD, Sumana Devata, MD, Angela E. Hawley, Susan A. Blackburn, RN, MBA, Satwinder Grewal, Martina V Hemmer, MA, Henry Flanner, MS, William Kramer, PhD, William E Parker, Yu-Ling Li, MS, MD, Daniel Durant Myers, DVM, MPH, James B. Froehlich, MD MPH, John L Magnani, PhD, Helen M. Thackray, MD, Thomas W. Wakefield, MD, Suman L. Sood, MD MSCE

Blood (2016) 128 (22): 3826.

https://doi.org/10.1182/blood.V128.22.3826.3826

Published: 2016

Journal Articles

A Phase I/II Study of GMI-1271, a Novel E-Selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Elderly Previously Untreated Acute Myeloid Leukemia; Results to Date

Daniel J. DeAngelo, MD PhD, Jane L. Liesveld, MD, Brian A Jonas, MD PhD, Michael E O'Dwyer, MD, Dale L. Bixby, MD, John L Magnani, PhD, Helen M. Thackray, MD, Pamela S. Becker, MD PhD

Blood (2016) 128 (22): 4049.

https://doi.org/10.1182/blood.V128.22.4049.4049

Published: 2016

Journal Articles

Increased Levels of Endothelial Dysfunction Markers and Matrix Metalloproteinases in Patients with Severe Post-Thrombotic Syndrome

Luis Fernando Bittar, PhD, Fernanda Andrade Orsi, MD PhD, Kiara Cristina Senger Zapponi, MSc, Bruna Moraes Mazetto, PhD, Erich Vinicius De Paula, Sr., MD PhD, Joyce Maria Annichino-Bizzacchi, MD PhD

Blood (2016) 128 (22): 276.

https://doi.org/10.1182/blood.V128.22.276.276

Published: 2016

Journal Articles

Simvastatin Reduces Frequency of Vaso-Occlusive Pain in Sickle Cell Disease: A Pilot Efficacy Trial

Carolyn C. Hoppe, MD, Eufemia Jacob, PhD RN, Frans A. Kuypers, PhD, Lori Styles, MD

Blood (2015) 126 (23): 545.

https://doi.org/10.1182/blood.V126.23.545.545

Published: 2015

Journal Articles

Posterior Reversible Encephalopathy Syndrome in Beta Thalassemia Major Transplants: A Single Center Experience

Amrith Mathew, MD, Chepsy C Philip, DM, M Joseph John, MD DM

Blood (2015) 126 (23): 5458.

https://doi.org/10.1182/blood.V126.23.5458.5458

Published: 2015

Journal Articles

PDE-9 Inhibition Combined with Hydroxyurea Is Beneficial in Vaso-Occlusive Crisis in Mouse Model of Sickle Cell Disease

Reema Jasuja, Sunita Patel Hett, Joachim Fruebis, PhD, Debra Pittman

Blood (2014) 124 (21): 2694.

https://doi.org/10.1182/blood.V124.21.2694.2694

Published: 2014

Journal Articles

Pan-Selectin Antagonist Rivipansel (GMI-1070) Reduces Soluble E-Selectin Levels While Improving Clinical Outcomes in SCD Vaso-Occlusive Crisis

Ted Wun, MD, Marilyn J. Telen, MD, Lakshmanan Krishnamurti, MD, Timothy L. McCavit, MD, Laura M DeCastro, MD, Henry Flanner, ME, Frans A. Kuypers, PhD, Sandra K. Larkin, MS, Seungshin Rhee, MS, John L. Magnani, PhD, Helen M. Thackray, MD

Blood (2014) 124 (21): 2704.

https://doi.org/10.1182/blood.V124.21.2704.2704

Published: 2014

Journal Articles

Determinants Of Heme-Oxygenase-1 Upregulation In Patients With Sickle Cell Disease

Olufolake Adisa, MD, Benjamin Yaw Owusu, B.S., Yijuan Hu, PhD, Samit Ghosh, PhD, Fang Tan, PhD, Frederika Sey, MD, Ivy Ekem, MD, Isaac Quaye, PhD, Solomon F Ofori-Acquah, PhD

Blood (2013) 122 (21): 2235.

https://doi.org/10.1182/blood.V122.21.2235.2235

Published: 2013

Journal Articles

Recombinant Thrombomodurin For The Treatment Of Transplantation-Associated Coagulopathy After Allogeneic Stem Cell Transplantation

Kazuyoshi Ishii, MD, MPH, PhD, Shosaku Nomura, MD, PhD, Tomoki Ito, MD, PhD, Yuta Katayama, MD, PhD, Taiichi Kyo, MD, Shuichi Ota, MD, PhD, Masanori Seki, MD, PhD, Shigeru Chiba, MD, PhD, Yoshinobu Maeda, M.D., Ph.D., Mitsune Tanimoto, MD, PhD, Takayuki Ikezoe, MD. PhD, Hideo Yagi, MD, PhD, Yoji Ishida, M.D., Ph.D., Naohito Fujishima, MD, PhD, Kenichi Sawada, MD, PhD

Blood (2013) 122 (21): 5454.

https://doi.org/10.1182/blood.V122.21.5454.5454

Published: 2013

Journal Articles

MCP-1 and VCAM-1 As Pathological Markers In a Patient With Infection Induced Hemophagocytic Syndrome After Stem Cell Transplantation

Kunio Hayashi, PhD/MD, Kazuhiro Ikegame, PhD/MD, Masafumi Ito, PhD/MD, Shosaku Nomura, PhD/MD

Blood (2013) 122 (21): 5465.

https://doi.org/10.1182/blood.V122.21.5465.5465

Published: 2013

Journal Articles

Clinical Characteristics Associated with Survival in Adult Sickle Cell Disease

Hany Elmariah, MD, Melanie E. Garrett, MS, Kenneth I. Ataga, MD, Allison E Ashley-Koch, PhD, Marilyn J. Telen, MD

Blood (2012) 120 (21): 3229.

https://doi.org/10.1182/blood.V120.21.3229.3229

Published: 2012

Journal Articles

Endothelial Glycocalyx Degradation Is Associated with Bleeding, Thrombocytopathy, Endothelial Disruption and Leukocytosis in Acute Myeloid Leukemia.

Anne Mette Larsen, MD, Eva Birgitte Leinøe, MD, PhD, Pär Johansson, MD, DMSc, Henrik Birgens, MD, DMSc, Sisse Rye Ostrowski, MD, PhD, DMSc

Blood (2012) 120 (21): 2173.

https://doi.org/10.1182/blood.V120.21.2173.2173

Published: 2012

NARROW

Effects of Targeting the Interleukin-1 Receptor in a Murine Model of Sickle Cell Disease

Neurological Adverse Events Following CAR-T Cell Therapy: A Real-World Analysis of Adult Patients Treated with Axicabtagene Ciloleucel or Tisagenlecleucel

The Effect of the Soluble Guanylate Cyclase Stimulator Olinciguat on Renal Function and Biomarkers of Inflammation and Renal Injury in Sickle Cell Mice

Elevated Axicabtagene Ciloleucel (CAR-19) Expansion By Immunophenotyping Is Associated with Toxicity in Diffuse Large B-Cell Lymphoma

Targeting Macrophage Activation in Hyperhemolysis Syndrome with Novel Use of Tocilizumab

The Clinical-Stage sGC Stimulator IW-1701 Prevents Increase of Plasma Biomarkers of Intravascular Inflammation and Suppresses Leukocyte-Endothelial Interactions in Tnfα-Treated Mice

Posterior Reversible Encephalopathy Syndrome (PRES) after Infusion of Anti-Bcma CAR T Cells (CART-BCMA) for Multiple Myeloma: Successful Treatment with Cyclophosphamide

Translation from SCD Mouse to Man: Chronic Administration of Tucaresol Reduces RBC Sickling and Improves Hematological Parameters, but Does Not Impact Inflammatory Markers in SCD Model Mice

E-Selectin Antagonist GMI-1271 Shows a Favorable Safety, PK and Bleeding Profile in Phase I Studies of Healthy Volunteers

A Phase I/II Study of GMI-1271, a Novel E-Selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Elderly Previously Untreated Acute Myeloid Leukemia; Results to Date

Increased Levels of Endothelial Dysfunction Markers and Matrix Metalloproteinases in Patients with Severe Post-Thrombotic Syndrome

Simvastatin Reduces Frequency of Vaso-Occlusive Pain in Sickle Cell Disease: A Pilot Efficacy Trial

Posterior Reversible Encephalopathy Syndrome in Beta Thalassemia Major Transplants: A Single Center Experience

PDE-9 Inhibition Combined with Hydroxyurea Is Beneficial in Vaso-Occlusive Crisis in Mouse Model of Sickle Cell Disease

Pan-Selectin Antagonist Rivipansel (GMI-1070) Reduces Soluble E-Selectin Levels While Improving Clinical Outcomes in SCD Vaso-Occlusive Crisis

Determinants Of Heme-Oxygenase-1 Upregulation In Patients With Sickle Cell Disease

Recombinant Thrombomodurin For The Treatment Of Transplantation-Associated Coagulopathy After Allogeneic Stem Cell Transplantation

MCP-1 and VCAM-1 As Pathological Markers In a Patient With Infection Induced Hemophagocytic Syndrome After Stem Cell Transplantation

Clinical Characteristics Associated with Survival in Adult Sickle Cell Disease

Endothelial Glycocalyx Degradation Is Associated with Bleeding, Thrombocytopathy, Endothelial Disruption and Leukocytosis in Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only